BridgeMD
New treatment option for Focal Acute Respiratory Distress Syndrome
Official title Ventilatory Strategy Based on Ultrasound Lung Morphology in Patients With Focal ARDS
ClinicalTrials.gov ID: NCT04966624
What this study is testing
- What it's testing
- ARDS is characterized by a diffuse, bilateral, extensive alveolar-interstitial infiltrate related to damage to the alveolar membrane. Studies of lung morphology assessed by CT scan have shown 2 types of ARDS.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- person who has given oral consent or has been included in an emergency
- Older than 18 years
- On mechanical ventilation for less than 24 hours
- Diagnosis of ARDS for less than 24 hours. ARDS according to the Berlin classification: i.e. arterial oxygen pressure to inspired oxygen fraction...
- Focal ARDS determined on pulmonary ultrasound
You likely can't join if
- person who is not a beneficiary of national health insurance
- person who is subject to a legal measure of protection (curatorship, guardianship)
- pregnant or breastfeeding women
- minor
- Patient having benefited from an invasive mechanical ventilation of more than one week in the previous month;
- ARDS in the previous month;
See the full eligibility criteria
- person who has given oral consent or has been included in an emergency
- Older than 18 years
- On mechanical ventilation for less than 24 hours
- Diagnosis of ARDS for less than 24 hours. ARDS according to the Berlin classification: i.e. arterial oxygen pressure to inspired oxygen fraction ratio less than or equal to 300, with a PEEP greater than or equal to 5...
- Focal ARDS determined on pulmonary ultrasound
- person who is not a beneficiary of national health insurance
- person who is subject to a legal measure of protection (curatorship, guardianship)
- pregnant or breastfeeding women
- minor
- Patient having benefited from an invasive mechanical ventilation of more than one week in the previous month;
- ARDS in the previous month;
- Chronic respiratory failure under NIV or long term oxygen;
- Severe acute asthma;
- Lobectomy;
- Pneumothorax;
- Pneumomediastinum;
- Pulmonary fibrosis;
- Morbid obesity with a BMI above 40 ;
- Cancer with metastasis;
- Bone marrow transplantation;
- Chemotherapy-induced neutropenia;
- Cirrhosis with a Child-Pugh score of C;
- Suspected or confirmed intracranial hypertension;
- Concurrent participation in another ARDS study;
- Extensive burns on the torso.
The study team makes the final eligibility decision.
Where it's taking place
- Dijon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dijon, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.